ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc.'s Overview
ARS Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to empowering patients and caregivers with innovative, easy-to-use treatments for severe allergic reactions. Their lead product candidate, neffy® (epinephrine nasal spray), is being developed as a needle-free alternative to epinephrine auto-injectors for the emergency treatment of Type I allergic reactions, including anaphylaxis. ARS is focused on bringing neffy® through regulatory approval and to the market to address the unmet needs of individuals at risk of life-threatening allergies.
Where is ARS Pharmaceuticals, Inc.'s Headquarters?
HQ Function
The San Diego headquarters serves as the primary center for ARS Pharmaceuticals' corporate leadership, clinical development oversight, regulatory affairs, and strategic business operations.
Notable Features:
Located in a modern office complex, the headquarters provides a collaborative environment conducive to research and development management. Its location offers access to a rich ecosystem of life science talent and resources.
Work Culture:
ARS Pharmaceuticals fosters a patient-focused, innovative, and agile work culture. The team is driven by a shared mission to develop and deliver a meaningful solution for people with severe allergies, emphasizing scientific excellence and collaboration.
HQ Significance:
The San Diego location is significant due to its proximity to world-class research institutions, a skilled workforce in the biotech sector, and a supportive environment for pharmaceutical development and commercialization.
Values Reflected in HQ: The headquarters reflects the company's commitment to innovation, efficiency, and a focused approach to bringing vital treatments to patients. It supports a lean and dynamic operational model.
Location:
While ARS Pharmaceuticals is headquartered in the United States, its operational scope and market aspirations are global. The company actively engages with regulatory authorities in key international markets, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), for its lead product candidate, neffy®. Clinical trials often involve international sites, and commercialization strategies are being developed for worldwide distribution to address the global need for improved emergency allergy treatments.
Street Address:
11682 El Camino Real, Suite 120
City:
San Diego
State/Province:
CA
Country:
USA
ARS Pharmaceuticals, Inc.'s Global Presence
Global (Partner-based Operations)
Address: N/A - Operations managed through a network of partners
To leverage specialized global expertise, infrastructure, and patient populations for efficient drug development, manufacturing scalability, and conducting clinical trials necessary for worldwide regulatory submissions and market access for neffy®.
Buying Intent Signals for ARS Pharmaceuticals, Inc.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of ARS Pharmaceuticals, Inc.
As of April 2025, ARS Pharmaceuticals, Inc.' leadership includes:
Investors of ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals, Inc. has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past year, ARS Pharmaceuticals strengthened its leadership by appointing a new Chief Business Officer to enhance its business development and corporate strategy efforts. No major C-suite departures were publicly announced during this period.
New Appointments:
Technology (Tech Stack) used by ARS Pharmaceuticals, Inc.
Discover the tools ARS Pharmaceuticals, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ARS Pharmaceuticals, Inc. Email Formats and Examples
ARS Pharmaceuticals likely employs a standard corporate email format using the company domain '@arspharma.com'. A common pattern is the first initial followed by the last name.
[first_initial][last]@arspharma.com
Format
jdoe@arspharma.com
Example
75%
Success rate
News and media
ARS Pharmaceuticals Investor Relations • May 28, 2024
ARS Pharmaceuticals Announces Publication of Clinical Study Data for Neffy® (Epinephrine Nasal Spray) in the Journal of Allergy and Clinical Immunology: In Practice
ARS Pharmaceuticals announced the publication of clinical study data for neffy® (epinephrine nasal spray) in JACI: In Practice. The study compared repeat doses of neffy® to repeat doses of epinephrine intramuscular injection under nasal allergen challenge conditions, demonstrating comparable pharmacokinetic profiles and efficacy....more
ARS Pharmaceuticals Investor Relations • May 9, 2024
ARS Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
ARS Pharmaceuticals reported its Q1 2024 financial results, highlighting ongoing regulatory reviews for neffy® in the U.S. and Europe. The company provided updates on its cash runway and preparedness for potential commercial launch activities pending approvals....more
ARS Pharmaceuticals Investor Relations • March 21, 2024
ARS Pharmaceuticals Announces European Medicines Agency Review of Neffy® (Epinephrine Nasal Spray) Marketing Authorization Application is Progressing with CHMP Opinion Expected in Q2 2024
ARS Pharmaceuticals announced that the European Medicines Agency's (EMA) review of the Marketing Authorization Application (MAA) for neffy® is progressing, with an opinion from the Committee for Medicinal Products for Human Use (CHMP) anticipated in the second quarter of 2024....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including ARS Pharmaceuticals, Inc., are just a search away.